Skip to Content

Notice

Memorandum of Understanding With Duke University

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and Duke University. The purpose of this MOU is to establish a framework for collaboration between the Parties and for pursuing specific collaborative projects. This collaboration between the Parties shall be known as the Cardiac Safety Research Consortium.

DATES:

The agreement became effective August 4, 2009.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Wendy R. Sanhai, Office of the Commissioner (HZ-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7867, FAX: 301-827-5891.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), Start Printed Page 46999which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: August 31, 2009.

David Horowitz,

Assitant Commissioner for Policy.

End Signature Start Printed Page 47000

Start Printed Page 47001

Start Printed Page 47002

Start Printed Page 47003

Start Printed Page 47004

Start Printed Page 47005

Start Printed Page 47006

Start Printed Page 47007

Start Printed Page 47008 End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. E9-22001 Filed 9-11-09; 8:45 am]

BILLING CODE 4160-01-C